Formulation and in vitro characterization of sodium alginate-gellan beads of glipizide

Acta Pharmaceutica Sciencia

Volumn 49, Issue 1, 2007, Pages 13-28

  Rao, V U ^a   Vasudha, M ^a   Bindu, K ^a   Samanta, S ^b   Rajinikanth, P S ^c   Mishra, B ^c   Balasubramaniam, J ^a  

^a ISP Hong Kong Limited   (India)

^b VIT UNIVERSITY   (India)

^c BANARAS HINDU UNIVERSITY   (India)

Author keywords

Beads; Controlled release; Gellan; Glipizide; Sodium alginate

Indexed keywords

ALGINIC ACID; GELLAN; GELRITE; GLIPIZIDE; POLYMER;

ARTICLE; CONCENTRATION (PARAMETERS); CROSS LINKING; DIFFUSION; DISSOLUTION; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; ENCAPSULATION; GELATION; IN VITRO STUDY; KINETICS; MORPHOLOGY; NONHUMAN; PHYSICAL CHEMISTRY; PREVALENCE; SWELLING;

EID: 42449147417     PISSN: 13072080     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Agnihotri, S.A. and Aminabhavi, T.M. (2005). Development of novel inter penetrating network gellan gum-poly(vinyl alcohol) hydrogel microspheres for the controlled release of Carvidilol. Drug Dev. Ind. Pharm. 31(6):491-503.
2. Agnihotri, S.A., Jawalkar, S.S. and Aminabhavi, T.M. (2006). Controlled release of cephalaxin through gellan gum beads; Effect of formulation parameters on entrapment efficiency, size and drug release. Eur. J. Pharm. Biopharm.63(3):249-61.
3. Alhaique, F., Santucci, E., Carafa, M., Coviello, M., Murtas, E. and Riccieri, M. (1996). Gellan in sustained release formulations: preparation of gel capsules and release studies. Biomaterials 17:1981-1986.
4. Almeida, F.P. and Almeida, A.J. (2004). Cross-linked alginate-gelatine beads: a new matrix for controlled release of pindolol. J. Controlled Rel. 97:431-439.
5. Badwan, A.A., Abumalooh, A., Sallam, E., Abukalaf, A. and Jawan, O. (1985). A sustained release drug delivery system using calcium alginate beads. Drug Dev. Ind. Pharm. 11:239-256.
6. Balasubramaniam, J. and Pandit, J.K. (2003). Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride. Drug Del. 10:185-91.
7. Balasubramaniam, J., Thilek Kumar, M., Barat, R., Pandit, J.K. and Mittal, N. (2004). Chitosan based periodontal pocket inserts - formulation, in vitro and preliminary clinical evaluation. Acta Pharm. Turc. 46:5-15.
8. Balasubramaniam, J., Vinay, U. Rao, Vasudha, M., Babu, J. and Rajinikanth, P.S. (2006). Sodium alginate microspheres of metformin HCl: Formulation and invitro evaluation. Curr. Drug Del. article in press.
9. 2 gas-forming agents. Int. J. Pharm. 239:81-91.
10. Crescenzi, V. (1995). Microbial polysaccharides of applied interest; ongoing research activities in Europe. Biotechnol.Prog. 11(3):251-9.
11. El-Fattah, A., Grant, D.J., Gabr, K.E. and Meshali, M.M. (1998). Physical characteristics release behaviour of salbutamol sulphate beads prepared with different ionic polysaccharides. Drug Dev. Ind. Pharm. 24(6):541-47.
12. Garcia, J. and Ghaly, E.S. (2001). Evaluation of bioadhesive glipizide spheres and compacts from spheres prepared by extruder/marumerizer technique. Pharm. Dev. Techno. 6(3):407-417.
13. Gaserod, O., Jolliffe, I.G., Hampson, F.C., Dettmar, P.W. and Skjak-Braek, G. (1998). The enhancement of the bioadhesive properties of calcium alginate gel beads by coating with chitosan. Int. J. Pharm. 175:237-246.
14. Grant, G.T., Morris, E.R., Rees, D.A., Smith, P.J.C. and Thom, D. (1973). Biological interactions between polysaccharides and divalent cations: The egg-box model. FEBS Lett. 32:195-198.
15. Gursoy, A. and Cevik, S. (2000). Sustained release properties of alginate microspheres of diclofenac sodium. J. Microencapsul. 17:565-575.
16. Haug, A. and Larsen, B. (1962). Quantitative determination of the uronic acid composition of alginates. Acta Chem. Scand. 16:1908-1918.
17. Haug, A., Larsen, B. and Smidsrod, O. (1967). Studies on the sequence of uronic acid residues in alginic acid. Acta Chem. Scand. 21:691-704.
18. Hoffman, A.S. (2002). Hydrogels for biomedical applications. Adv. Drug Del. Rev. 54:3-32.
19. Imai, T., Kawasaki, C., Nishiyama, T. and Otagiri, M. (1993). Preparation and eavaluation of controlled release formulation of nifedipine using alginate gel beads. Biol. Pharm. Bull. 16:420-424.
20. Korsmeyer R.W., Gurney R., Doelker E., Buri P. and Peppas N.A. (1983). Mechanisms of solute release from porous hydrophilicpolymers. J. Pharm. Sci. 15:25-35.
21. Kudela, V. (1989). Hydrogels, in: H.F. Mark (Ed.), Encyclopedia of Polymer Science and Engineering, vol. 7, Wiley, New York, pp. 703-807.
22. Kulkarni, A.R., Soppimath, K.S., Aminabhavi, T.M. and Rudzinski, W.E. (2001). In vitro release kinetics of cefadroxil-loaded sodium alginate interpenetrating network beads. Eur. J. Pharm. Biopharm. 63:97-105.
23. Miyazaki, S., Kawasaki, N., Kudo, W. and Attwood, D. (2001). Comparison of in situ gelling formulation for oral delivery of cimetidine. Int. J. Pharm. 220:161-168.
24. Mumper, R.J., Hoffman, A.S., Puolakkainen, A., Bouchard, L.S. and Gombotz, W.R. (1994). Calcium alginate beads for the oral delivery of TGF-beta 1. J. Control. Rel. 30:241-251.
25. Murata, Y., Jinno, D., Kofuji, K. and Kawashima, S. (2004). Properties of calcium-induced gel beads prepared with alginate and hydrolysates. Chem. Pharm. Bull. 52(5):605-607.
26. Patil, S., Sharma, S., Nimbalkar, A. and Pawar, A. Study of formulation variables on properties of drug-gellan beads by factorial design. (2006). Drug Dev. Ind. Pharm. 32(3):315-26.
27. Quigley, K.J. and Deasy, P.B. (1992). Use of deacetylated gellan gum (Gelrite) for the production of Sulphamethizole containing beads. J. Microencapsulation 9(1):1-7.
28. Rajinikanth, P.S., Sankar, C. and Mishra, B. (2003). Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: Development and evaluation. Drug Deliv. 10:21-28.
29. Risbud, M.V. and Bhonde, R.R. (2000). Polyacrylamide-chitosan hydrogels: in vitro biocompatibility and sustained antibiotic release studies. Drug Deliv. 7:69-75.
30. Rozier, A., Mazuel, C., Grove, J. and Plazonet, B. (1989). A novel ion activated insitu gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. Int. J. Pharm. 57:163-168.
31. Sanzgiri, Y.D., Maschi, V. and Crescenzi, L. (1993). Gellan based systems for ophthalmic sustained delivery of methyl prednisolone. J. Control. Rel. 26:195-201.
32. Soppimath, K.S., Aminabhavi, T.M., Dave, A.M., Kumbar, S.G. and Rudzinski, W.E. (2002). Stimulus-responsive smart hydrogels as novel drug delivery systems. Drug Dev. Ind. Pharm. 28:957-974.
33. th annual meeting of Pharmaceutical Society of Japan, Sapporo, abstract part 4 118.
34. Thanoo, B.C., Sunny, M.C. and Jayakrishnan, A. (1992). Cross-linked chitosan microspheres: preparation and evaluation as matrix for controlled release of pharmaceuticals. J. Pharm. Pharmacol. 44:283-286.
35. Thom, D., Grant, G.T., Morris, E.R. and Rees, D.A. (1982). Characterization of cation binding and gelation of polyuronates by circular dichroism. Carbohydr. Res. 100:29-42.
36. Torre, M.L., Giunchedi, L., Maggi, R., Stefli, E., Machiste, O. and Conte, U. (1998). Formulation and characterization of calcium alginate beads containing ampicillin. Pharm. Dev. Technol. 3:193-198.
37. Verma, R.K. and Garg, S. (2004). Development and evaluation of osmotically controlled oral drug delivery system of glipizide. Eur. J. Pharm. Biopharm. 57(3):513-25.